7CB0

The apo 6-phosphogluconate dehydrogenase from Staphylococcus aureus (strain Newman)

Summary for 7CB0

• Entry DOI: 10.2210/pdb7cb0/pdb
• Descriptor: 6-phosphogluconate dehydrogenase, decarboxylating (2 entities in total)
• Functional Keywords: pentose phosphate pathway, decarboxylating, cytosolic protein
• Biological source: Staphylococcus aureus (strain Newman)
• Total number of polymer chains: 4
• Total formula weight: 207430.36

Authors

Wang, H.,Wang, M.,Sun, H. (deposition date: 2020-06-10, release date: 2021-04-07, Last modification date: 2024-03-27)

Primary citation

Wang, H.,Wang, M.,Xu, X.,Gao, P.,Xu, Z.,Zhang, Q.,Li, H.,Yan, A.,Kao, R.Y.,Sun, H.
Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance.
Nat Commun, 12:3331-3331, 2021

PubMed Abstract: The rapid emergence of drug resistant Staphylococcus aureus (S. aureus) poses a serious threat to public health globally. Silver (Ag)-based antimicrobials are promising to combat antibiotic resistant S. aureus, yet their molecular targets are largely elusive. Herein, we separate and identify 38 authentic Ag-binding proteins in S. aureus at the whole-cell scale. We then capture the molecular snapshot on the dynamic action of Ag against S. aureus and further validate that Ag could inhibit a key target 6-phosphogluconate dehydrogenase through binding to catalytic His185 by X-ray crystallography. Significantly, the multi-target mode of action of Ag (and nanosilver) endows its sustainable antimicrobial efficacy, leading to enhanced efficacy of conventional antibiotics and resensitization of MRSA to antibiotics. Our study resolves the long-standing question of the molecular targets of silver in S. aureus and offers insights into the sustainable bacterial susceptibility of silver, providing a potential approach for combating antimicrobial resistance.

PubMed: 34099682
DOI: 10.1038/s41467-021-23659-y

Experimental method

X-RAY DIFFRACTION (2.52 Å)